Literature DB >> 2583625

[Problems and characteristics of the orthodontic treatment of a patient with adrenogenital syndrome].

J W Schlupper-Beckmann, M Lücke, R Mallmann.   

Abstract

This article describes biochemical relationships accompanying pathological symptoms of C-21-hydroxylase deficiency (adrenogenital syndrome). Disturbances of bone growth and development have been observed, even during medical treatment. A discrepancy of 2 1/2 years was noted between the patients chronological age and his bone development. The patient reaches a maximum height of 155 to 160 cm. Supernumeraries and delayed mineralisation are to be expected. Surgical procedures require an increase in cortisone dosage. When considering orthodontic treatment, one must determine the most appropriate time to start, take into account the long retention period and pay particular attention to oral hygiene.

Entities:  

Mesh:

Year:  1989        PMID: 2583625     DOI: 10.1007/bf02171177

Source DB:  PubMed          Journal:  Fortschr Kieferorthop        ISSN: 0015-816X


  22 in total

1.  Congenital adrenal hyperplasia: renin and steroid values during treatment.

Authors:  D B Grant; M J Dillon; S M Atherden; R J Levinsky
Journal:  Eur J Pediatr       Date:  1977-08-23       Impact factor: 3.183

2.  Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitary-adrenal function.

Authors:  A W Meikle; F H Tyler
Journal:  Am J Med       Date:  1977-08       Impact factor: 4.965

3.  Adrenal hyperplasia--a case report of delayed onset of the congenital form or an acquired form.

Authors:  V B Mahesh; R B Greenblatt; R F Coniff
Journal:  J Clin Endocrinol Metab       Date:  1968-05       Impact factor: 5.958

4.  [Congenital adrenal hyperplasia with total virilisation (penile urethra). Review of the cases described in the world literature and case report of one personal observation].

Authors:  H Stolecke
Journal:  Z Kinderheilkd       Date:  1970

5.  Prediction of mandibular growth rotation.

Authors:  A Björk
Journal:  Am J Orthod       Date:  1969-06

6.  Detection of heterozygotes for congenital adrenal hyperplasia: 21-hydroxylase deficiency-a comparison of HLA typing and 17-OH progesterone response to ACTH infusion.

Authors:  R S Mauseth; J A Hansen; E K Smith; E R Giblett; V C Kelley
Journal:  J Pediatr       Date:  1980-11       Impact factor: 4.406

Review 7.  Adrenal 21-hydroxylase cytochrome P-450 genes within the MHC class III region.

Authors:  P C White; M I New; B Dupont
Journal:  Immunol Rev       Date:  1985-10       Impact factor: 12.988

8.  17-hydroxyprogesterone, androstenedione, and testosterone in normal children and in prepubertal patients with congenital adrenal hyperplasia.

Authors:  K von Schnakenburg; F Bidlingmaier; D Knorr
Journal:  Eur J Pediatr       Date:  1980-05       Impact factor: 3.183

9.  Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.

Authors:  H Frisch; K Parth; E Schober; W Swoboda
Journal:  Arch Dis Child       Date:  1981-03       Impact factor: 3.791

10.  Continuing need for mineralocorticoid therapy in salt-losing congenital adrenal hyperplasia.

Authors:  I A Hughes; A Wilton; C A Lole; O P Gray
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.